-+ 0.00%
-+ 0.00%
-+ 0.00%

ASP Isotopes forecasts FY 2026 PET Labs revenue about $14 million

PUBT·08/04/2026 12:02:32
Listen to the news
ASP Isotopes forecasts FY 2026 PET Labs revenue about $14 million
  • ASP Isotopes forecast FY 2026 PET Labs revenue of about $14 million, versus $6 million in 2025; 1H organic revenue growth topped 50%.
  • Renergen helium production expected to start before Sept. 30, 2026; Phase 1 annualized helium and LNG revenue forecast near $27 million.
  • Renergen Phase 1 pricing assumptions include helium above USD 600 per Mcf; LNG at USD 15-18 per GJ; revenue recognition expected in 2H 2026.
  • Phase 2 construction expected to start in 2H 2026; planned 44-month build; targeted funding includes USD 750 million of senior debt.
  • Phase 2 nameplate revenue potential projected above $360 million annually; group 2031 EBITDA target set above $300 million.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. ASP Isotopes Inc. published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202608040800PRIMZONEFULLFEED9803187) on August 04, 2026, and is solely responsible for the information contained therein.